News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
USPSTF recommends all women undergo routine breast cancer screening every other year beginning at age 40 – JAMA Oncology
Photo from JAMA Oncology/X
Jun 14, 2024, 14:42

USPSTF recommends all women undergo routine breast cancer screening every other year beginning at age 40 – JAMA Oncology

JAMA Oncology shared on X/Twitter:

“From JAMA: USPSTF recommends all women undergo routine breast cancer screening every other year beginning at age 40, an update from the 2016 recommendation to start at age 50.”

Visit the article website.
Source: JAMA Oncology/X

Breast Cancer breast cancer screening cancer JAMA JAMA Oncology OncoDaily Oncology USPSTF
Special Coverage
Career
Jan 16, 2025, 14:12
St. Jude Global Critical Care team is looking for a Clinical Research Scientist
Career
Jan 16, 2025, 14:06
Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono
Blog
Jan 16, 2025, 13:56
Miriam Mutebi: Stories like Claire’s haunt us as clinicians
Blog
Jan 16, 2025, 13:39
NHS England starts sending bowel cancer screening tests to over-50s
Blog
Jan 16, 2025, 13:38
Justin Stebbing: Princess of Wales "in remission" from cancer
Career
Jan 16, 2025, 13:33
Daniel Mckenzie: Started my role at KidzCan Zimbabwe as an Executive Director
Science
Jan 16, 2025, 13:29
Chang-il Hwang: How organoid technology is transforming pancreatic cancer research
Blog
Jan 16, 2025, 13:22
Prisca Githuka: I rang the bell at the finish line after 10 years of being on Cancer hormonal treatment
Blog
Jan 16, 2025, 13:21
Akhil Santhosh: Prevention of dermatologically adverse events with amivantamab combinations
Radiotherapy
Jan 16, 2025, 13:14
What Is Palliative Radiotherapy and How It Works? Pros and Cons
Opinion
Jan 16, 2025, 13:08
Amol Akhade: OS difference in first line Cdk inhibitors plus AI, amongst Palbociclib, Ribociclib and abemaciclib in MBC
Blog
Jan 16, 2025, 12:53
International Pediatric Onco-Critical Care Symposium